SUPPRESSION OF VENTRICULAR-FIBRILLATION AND POSITIVE INOTROPIC ACTION OF BETHANIDINE SULFATE, A CHEMICAL ANALOG OF BRETYLIUM TOSYLATE THAT IS WELL ABSORBED ORALLY

被引:33
作者
BACANER, MB
HOEY, MF
MACRES, MG
机构
关键词
D O I
10.1016/0002-9149(82)90276-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:45 / 55
页数:11
相关论文
共 51 条
[1]   CLINICAL PHARMACOKINETICS OF INTRAVENOUS AND ORAL BRETYLIUM TOSYLATE IN SURVIVORS OF VENTRICULAR-TACHYCARDIA OR FIBRILLATION - CLINICAL-APPLICATION OF A NEW ASSAY FOR BRETYLIUM [J].
ANDERSON, JL ;
PATTERSON, E ;
WAGNER, JG ;
JOHNSON, TA ;
LUCCHESI, BR ;
PITT, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (03) :485-499
[2]   BRETYLIUM TOSYLATE FOR SUPPRESSION OF INDUCED VENTRICULAR FIBRILLATION [J].
BACANER, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1966, 17 (04) :528-&
[3]  
BACANER M, 1970, MT SINAI J MED, V37, P247
[4]  
BACANER M, 1967, FED PROC, V26, P444
[5]  
BACANER M, 1971, GERIATRICS, V28, P834
[6]   QUANTITATIVE COMPARISON OF BRETYLIUM WITH OTHER ANTIFIBRILLATORY DRUGS [J].
BACANER, MB .
AMERICAN JOURNAL OF CARDIOLOGY, 1968, 21 (04) :504-&
[7]   BRETYLIUM TOSYLATE FOR SUPPRESSION OF VENTRICULAR FIBRILLATION AFTER EXPERIMENTAL MYOCARDIAL INFARCTION [J].
BACANER, MB ;
SCHRIENEMACHERS, D .
NATURE, 1968, 220 (5166) :494-+
[9]   INDUCED CHANGE IN HEART METABOLISM AS A PRIMARY DETERMINANT OF HEART PERFORMANCE [J].
BACANER, MB ;
LIOY, F ;
VISSCHER, MB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1965, 209 (03) :519-+
[10]  
BACANER MB, 1979, CURRENT SCI CLIN EXP, P7